The US Food and Drug Administration has approved the use of a novel painkiller as an effective treatment for short-term ...

Announcing a new publication for Acta Materia Medica journal. Prostate cancer (PrCa) is the most prevalent urogenital cancer affecting men.

Announcing a new publication for Acta Materia Medica journal. Prostate cancer (PrCa) is the most prevalent urogenital cancer affecting men.

University of Kentucky Markey Cancer Center researchers have discovered a promising new way to combat therapy-resistant ...

A test for pee-based markers of prostate cancer has previously relied on an uncomfortable first step. A new study has ...

ONTARIO—The Ontario government is connecting more people to care by being the first Canadian jurisdiction to publicly fund and administer PLUVICTO, a new treatment for advanced-stage prostate cancer, ...

Some oncologists suggest that, for certain early cancers not at risk of spreading, the term “cancer” should be avoided.

Prostate cancer (PC) is a prevalent malignancy among males and ranks as the fifth leading cause of cancer-related deaths globally. Factors such as age, ...

However, there are some key red flag symptoms of prostate cancer that should never be ignored, according to experts and the ...

The Mount Sinai Hospital has performed New York City's first procedure using the HYDROS™ Robotic System, a cutting-edge technology designed to treat ...

Prostate cancer has become the most commonly diagnosed cancer in England, according to new analysis.

Prostate cancer has become the most commonly diagnosed cancer in England, according to new analysis.